- Deals, deals, deals; Biohaven takes on Eli Lilly; and moreWelcome back to Endpoints Weekly! Don’t miss Ryan Cross’ deep dive into the paranoia caused by competition with China. Ryan writes that US biotech companies are holding their cards close to the ...Endpoints · 14d ago↗ source
- Apnimed files for IPO as FDA reviews its sleep apnea drugApnimed is finally going forward with an IPO attempt after years of flirting with the milestone. The Cambridge, MA-based biotech revealed its Nasdaq plans on Friday night, following a strong six ...Endpoints · 14d ago↗ source
- Nominee for key federal health role has a history of questioning vaccinesSean Kaufman's views on vaccines may put him at odds with Sen. Bill Cassidy during next week's confirmation hearing.STAT · 15d ago